Susan Hasty, Publisher
Table of Contents . . . April 15th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Pathogenesis - Cocaine increases HIV infection risk
Kaposi Sarcoma - Matrix metalloproteinase inhibitor effective for AIDS patients
AIDS and HIV Pathogenesis - HIV immune evasion not due to apoptosis resistance
AIDS and HIV Testing - Serotype testing suitable for large-scale use
AIDS and HIV Therapy - Efavirenz best choice for initial antiretroviral regimen
AIDS and HIV Therapy - Infected apoptotic cells can be used to promote antiviral responses
AIDS Therapy - Next generation NNRTI, TMC125, shows antiviral effect in patients failing HIV therapy
AIDS Therapy - Remune study results for Thai NDA released
Acute Care - High turnover rate may undermine HIV/hemophilia care
Finance - Company reports fourth quarter, year-end results
Finance - Company sees lower revenues and smaller losses in fourth quarter and year 2001
HIV Replication - Ciphergen signs agreement with the NIAID for AIDS research
HIV Research - Gates foundation to fund pilot anti-AIDS study using seaweed
Immunology - Intranasal delivery of HIV-1 antigen with adjuvant may induce potent immune responses
Laboratory Animals - Scientists warn that sale of primate meat could hamper medical research and harm human health
Pediatrics AIDS - Expert cites new opportunities to prevent perinatal HIV infection
Policy - South African government criticizes plans over AIDS drug
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.